Levalbuterol tartrate is primarily used as a bronchodilator to treat or prevent bronchospasm in individuals with reversible obstructive airway diseases, such as asthma and chronic obstructive pulmonary disorder (COPD). It works by relaxing the muscles in the airways, allowing for easier breathing.

This medication is often administered via inhalation, using a nebulizer or inhaler, making it effective for quick relief during acute asthma attacks or episodes of breathing difficulty. It is also used prophylactically before exercise or exposure to allergens to prevent bronchospasm.

Levalbuterol tartrate is particularly beneficial for patients who may experience side effects from other bronchodilators, as it contains only the active R-enantiomer of albuterol, which is responsible for the therapeutic effects, potentially reducing adverse reactions.

It is important for patients to use this medication as prescribed, as overuse can lead to decreased effectiveness or increased risk of side effects. Regular monitoring and consultation with a healthcare provider are recommended to ensure optimal management of respiratory conditions.